PMC:7534795 / 102661-102943 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T569","span":{"begin":54,"end":62},"obj":"Disease"}],"attributes":[{"id":"A569","pred":"mondo_id","subj":"T569","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Interestingly, recent data indicates individuals with COVID-19 who are being treated with ACE inhibitors or ARBs, for pre-existing conditions, are at lower risk of 28-day all-cause mortality than those not treated with ACE inhibitors or ARBs (Wang et al., 2020; Zhang et al., 2020)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T71","span":{"begin":90,"end":104},"obj":"Chemical"},{"id":"T14183","span":{"begin":94,"end":104},"obj":"Chemical"},{"id":"T61185","span":{"begin":219,"end":233},"obj":"Chemical"},{"id":"T22919","span":{"begin":223,"end":233},"obj":"Chemical"}],"attributes":[{"id":"A34462","pred":"chebi_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/CHEBI_35457"},{"id":"A59409","pred":"chebi_id","subj":"T14183","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A31295","pred":"chebi_id","subj":"T61185","obj":"http://purl.obolibrary.org/obo/CHEBI_35457"},{"id":"A25186","pred":"chebi_id","subj":"T22919","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"Interestingly, recent data indicates individuals with COVID-19 who are being treated with ACE inhibitors or ARBs, for pre-existing conditions, are at lower risk of 28-day all-cause mortality than those not treated with ACE inhibitors or ARBs (Wang et al., 2020; Zhang et al., 2020)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T644","span":{"begin":0,"end":282},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Interestingly, recent data indicates individuals with COVID-19 who are being treated with ACE inhibitors or ARBs, for pre-existing conditions, are at lower risk of 28-day all-cause mortality than those not treated with ACE inhibitors or ARBs (Wang et al., 2020; Zhang et al., 2020)."}

{"project":"2_test","denotations":[{"id":"33031856-32302265-84039117","span":{"begin":276,"end":280},"obj":"32302265"}],"text":"Interestingly, recent data indicates individuals with COVID-19 who are being treated with ACE inhibitors or ARBs, for pre-existing conditions, are at lower risk of 28-day all-cause mortality than those not treated with ACE inhibitors or ARBs (Wang et al., 2020; Zhang et al., 2020)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2872","span":{"begin":90,"end":93},"obj":"Gene"},{"id":"2873","span":{"begin":219,"end":222},"obj":"Gene"},{"id":"2893","span":{"begin":54,"end":62},"obj":"Disease"},{"id":"2894","span":{"begin":181,"end":190},"obj":"Disease"}],"attributes":[{"id":"A2872","pred":"tao:has_database_id","subj":"2872","obj":"Gene:1636"},{"id":"A2873","pred":"tao:has_database_id","subj":"2873","obj":"Gene:1636"},{"id":"A2893","pred":"tao:has_database_id","subj":"2893","obj":"MESH:C000657245"},{"id":"A2894","pred":"tao:has_database_id","subj":"2894","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Interestingly, recent data indicates individuals with COVID-19 who are being treated with ACE inhibitors or ARBs, for pre-existing conditions, are at lower risk of 28-day all-cause mortality than those not treated with ACE inhibitors or ARBs (Wang et al., 2020; Zhang et al., 2020)."}